policy
The Global Institute for Talented Education at KAIST has begun providing middle and high school students with in-depth online science education.
The institute receives applications until March 20, 2016. For details, please refer to the website: http://talented.kaist.ac.kr.
The program will run from March 21, 2016 to June 13, 2016.
Any middle and high school student can take courses on mathematics, science (physics, chemistry and biology), and information system (C language and Python computer language) based on their levels and needs. A total of 23 courses will be offered at the level of the first year of middle school to the second year of high school.
The online lecturers are drawn from science-magnet high schools nationwide. They will lead the classes to become more interactive with students, encouraging discussions and questions and answers.
KAIST students will also take part as tutors, helping the middle and high school students better understand the basic concept of the subjects they undertake and and to think creatively to solve problems.
About 500 top students will be chosen from the online course applicants to participate in a science camp hosted by KAIST during summer and winter vacations.
-
research Editing Parkinson's Disease – KAIST Makes World's First Discovery of an Inflammatory RNA Editing Enzyme
< Professor Minee Choi of the Department of Brain and Cognitive Sciences (top left). Professor Sonia Gandhi (top right) and Professor Klenerman of the University College London (bottom right) > Parkinson's disease (PD) is a neurodegenerative disorder in which the α-synuclein protein abnormally aggregates within brain cells, causing neuronal damage. Through international collaboration, researchers at KAIST have revealed that RNA editing plays a crucial role in regulating neuroi
2025-05-02 -
event KAIST Art Museum Showcases the Works of Van Gogh, Cy Twombly, and More at "The Vault of Masterpieces"
KAIST (President Kwang Hyung Lee) opened a special exhibition "The Vault of Masterpieces" featuring the architects of the Gallerist Hong Gyu Shin, who is active in New York, on April 29th. Since its opening in December 2024, the KAIST Museum of Art, which has mainly exhibited works from its own collection, has boldly invited internationally renowned gallerist Shin Hong-gyu to hold its first full-scale special exhibition, displaying a large number of his collections in the center of the campus
2025-04-30 -
research KAIST sends out Music and Bio-Signs of Professor Kwon Ji-yong, a.k.a. G-Dragon, into Space to Pulsate through Universe and Resonate among Stars
KAIST (President Kwang-Hyung Lee) announced on the 10th of April that it successfully promoted the world’s first ‘Space Sound Source Transmission Project’ based on media art at the KAIST Space Research Institute on April 9th through collaboration between Professor Jinjoon Lee of the Graduate School of Culture Technology, a world-renowned media artist, and the global K-Pop artist, G-Dragon. This project was proposed as part of the ‘AI Entertech Research Center’ be
2025-04-10 -
event KAIST, Galaxy Corporation Hold Signboard Ceremony for ‘AI Entertech Research Center’
KAIST (President Kwang-Hyung Lee) announced on the 9th that it will hold a signboard ceremony for the establishment of the ‘AI Entertech Research Center’ with the artificial intelligence entertech company, Galaxy Corporation (CEO Yong-ho Choi) at the main campus of KAIST. < (Galaxy Corporation, from center to the left) CEO Yongho Choi, Director Hyunjung Kim and related persons / (KAIST, from center to the right) Professor SeungSeob Lee of the Department of Mechanical Engineer
2025-04-09 -
research KAIST Identifies Master Regulator Blocking Immunotherapy, Paving the Way for a New Lung Cancer Treatment
Immune checkpoint inhibitors, a class of immunotherapies that help immune cells attack cancer more effectively, have revolutionized cancer treatment. However, fewer than 20% of patients respond to these treatments, highlighting the urgent need for new strategies tailored to both responders and non-responders. KAIST researchers have discovered that 'DEAD-box helicases 54 (DDX54)', a type of RNA-binding protein, is the master regulator that hinders the effectiveness of immunotherapy—opening
2025-04-08